A phase II study of gefitinib as a dirst-line therapy of advanced or metastatic adenocarcinoma of the lung in lifetime non-smokers

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7072-7072 ◽  
Author(s):  
D. H. Lee ◽  
J. Y. Han ◽  
H. G. Lee ◽  
J. J. Lee ◽  
E. K. Lee ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Adenocarcinoma ◽  
Adenocarcinoma Of The Lung ◽  
Line Therapy

Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer

Oncology ◽  
2009 ◽  
Vol 76 (4) ◽  
pp. 270-274 ◽  
Author(s):  
Joanna M. Brell ◽  
Khalid Matin ◽  
Terry Evans ◽  
Robert L. Volkin ◽  
Gauri J. Kiefer ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Pancreatic Cancer ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Pretreated Patients

Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma

2009 ◽  
Vol 19 (3) ◽  
pp. 185-192 ◽  
Author(s):  
Tim Eisen ◽  
José Thomas ◽  
Wilson H. Miller ◽  
Martin Gore ◽  
Pascal Wolter ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Advanced Malignant Melanoma

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

2011 ◽  
Vol 13 (3) ◽  
pp. 179-184 ◽  
Author(s):  
Cristina Grávalos ◽  
Carlos Gómez-Martín ◽  
Fernando Rivera ◽  
Inmaculada Alés ◽  
Bernardo Queralt ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Gastroesophageal Junction ◽  
First Line ◽  
Her2 Positive ◽  
First Line Therapy ◽  
Gastroesophageal Junction Cancer ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document